Literature DB >> 18568088

Neuroticism, Side Effects, and Health Perceptions Among HIV-Infected Individuals on Antiretroviral Medications.

Mallory O Johnson1, Torsten B Neilands.   

Abstract

Side effects from antiretroviral therapy (ART) for HIV disease can deter treatment, impact quality of life, and impede medication adherence. Individual differences in neuroticism may account for variations in the experience of side effects and perceptions of health status. Cross-sectional assessments were conducted with 258 HIV-infected participants with confirmed HIV infection and current ART regimen. Structural equation modeling (SEM) was used to evaluate a model of self-reported ART side effect frequency and severity and perceived health status, as related to symptoms of neuroticism. Symptoms of neuroticism were associated with greater reports of ART side effects and poorer perceived health but unrelated to reported CD4 count and viral load. A structural model was supported in which greater symptoms of neuroticism are linked to poorer perceived health through greater side effect frequency and severity. Individual differences in symptoms of neuroticism can explain variations in side effect reporting and consequential impairments in perceived health in the context of HIV treatment. Identification and intervention with individuals high in symptoms of neuroticism may be warranted to alleviate side effect-related concerns and maximize treatment benefit.

Entities:  

Year:  2007        PMID: 18568088      PMCID: PMC2435048          DOI: 10.1007/s10880-007-9056-9

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  49 in total

1.  Mediation in experimental and nonexperimental studies: new procedures and recommendations.

Authors:  Patrick E Shrout; Niall Bolger
Journal:  Psychol Methods       Date:  2002-12

2.  The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART.

Authors:  Mallory O Johnson; Tanya Stallworth; Torsten B Neilands
Journal:  AIDS Behav       Date:  2003-06

3.  Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease.

Authors:  W E Cunningham; H M Rana; M F Shapiro; R D Hays
Journal:  J Clin Epidemiol       Date:  1997-07       Impact factor: 6.437

4.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

Review 5.  HIV medicine: drug side effects and interactions.

Authors:  C M Bates
Journal:  Postgrad Med J       Date:  1996-01       Impact factor: 2.401

6.  Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology.

Authors:  C F Turner; L Ku; S M Rogers; L D Lindberg; J H Pleck; F L Sonenstein
Journal:  Science       Date:  1998-05-08       Impact factor: 47.728

7.  Predictors of substance use frequency and reductions in seriousness of use among persons living with HIV.

Authors:  Marguerita Lightfoot; Tyson Rogers; Risë Goldstein; Mary Jane Rotheram-Borus; Susanne May; Sheri Kirshenbaum; Lance Weinhardt; Cathy Zadoretzky; Lauren Kittel; Mallory Johnson; Cheryl Gore-Felton; Stephen F Morin
Journal:  Drug Alcohol Depend       Date:  2005-02-14       Impact factor: 4.492

8.  Measures of neuroticism and disease status in coronary angiography patients.

Authors:  J C Barefoot; J C Beckham; B L Peterson; T L Haney; R B Williams
Journal:  J Consult Clin Psychol       Date:  1992-02

9.  Neuroticism and depressive symptoms among spouse caregivers: do health behaviors mediate this relationship?

Authors:  Mary P Gallant; Cathleen M Connell
Journal:  Psychol Aging       Date:  2003-09

10.  The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers.

Authors:  C Davis; E Ralevski; S H Kennedy; C Neitzert
Journal:  J Clin Psychopharmacol       Date:  1995-10       Impact factor: 3.153

View more
  7 in total

1.  Does Age Influence the Frequency of Anxiety Symptoms and Disorders in HIV Disease?

Authors:  Charles P Brandt; David P Sheppard; Michael J Zvolensky; Erin E Morgan; J Hampton Atkinson; Steven Paul Woods
Journal:  J HIV AIDS Soc Serv       Date:  2016-06-28

2.  Decreases in Self-Reported ART Adherence Predict HIV Viremia Among Pregnant and Postpartum South African Women.

Authors:  Tamsin K Phillips; Ira B Wilson; Kirsty Brittain; Allison Zerbe; Claude A Mellins; Robert H Remien; Catherine Orrell; Elaine J Abrams; Landon Myer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-03-01       Impact factor: 3.731

3.  Suicidal ideation is associated with HIV transmission risk in men who have sex with men.

Authors:  Adam W Carrico; Torsten B Neilands; Mallory O Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

4.  HIV Disease Impact on Mothers: What They Miss During Their Children's Developmental Years.

Authors:  Debra A Murphy; Kathleen Johnston Roberts; Diane M Herbeck
Journal:  J Child Fam Stud       Date:  2010-07-24

5.  Self-Reported Side Effects and Adherence to Antiretroviral Therapy in HIV-Infected Pregnant Women under Option B+: A Prospective Study.

Authors:  Tamsin Phillips; Annibale Cois; Robert H Remien; Claude A Mellins; James A McIntyre; Greg Petro; Elaine J Abrams; Landon Myer
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

6.  Medication Adherence and Associated Factors in Patients With Type 2 Diabetes: A Structural Equation Model.

Authors:  Jing Huang; Shenglan Ding; Shuyuan Xiong; Zhiping Liu
Journal:  Front Public Health       Date:  2021-11-04

7.  How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials.

Authors:  Elizabeth N Allen; Adiel K Mushi; Isolide S Massawe; Lasse S Vestergaard; Martha Lemnge; Sarah G Staedke; Ushma Mehta; Karen I Barnes; Clare I R Chandler
Journal:  BMC Med Res Methodol       Date:  2013-11-14       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.